Cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty.
Shoaib
Amer
A
Jayasekera
Narlaka
N
Oktaba
Monika
M
Roach
Richard T
RT
D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects*; D003362:Cost-Benefit Analysis; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000191:economics*; D006801:Humans; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors
D005343:Fibrinolytic Agents